AAAAAA
Results: 1-25/80
Authors:
MORI S
JEWETT A
CAVALCANTI M
MURAKAMIMORI K
NAKAMURA S
BONAVIDA B
Citation: S. Mori et al., DIFFERENTIAL REGULATION OF HUMAN NK CELL-ASSOCIATED GENE-EXPRESSION FOLLOWING ACTIVATION BY IL-2, IFN-ALPHA AND PMA IONOMYCIN/, International journal of oncology, 12(5), 1998, pp. 1165-1170
Authors:
FROST P
BONAVIDA B
Citation: P. Frost et B. Bonavida, DRUG-MEDIATED IMMUNOSENSITIZATION OF PROSTATE-CANCER CELLS TO FAS LIGAND-MEDIATED APOPTOSIS - INDEPENDENCE OF DE-NOVO PROTEIN-SYNTHESIS, The FASEB journal, 12(4), 1998, pp. 1634-1634
Authors:
GARBAN HJ
BONAVIDA B
Citation: Hj. Garban et B. Bonavida, NITRIC-OXIDE UP-REGULATES FAS RECEPTOR EXPRESSION AND SENSITIZES HUMAN OVARIAN-CARCINOMA CELL-LINES (A2780 AND AD10) TO FAS-MEDIATED APOPTOSIS, The FASEB journal, 12(4), 1998, pp. 1643-1643
Authors:
JEWETT A
BONAVIDA B
Citation: A. Jewett et B. Bonavida, REGULATION OF ANTI-CD16-MEDIATED APOPTOSIS IN HUMAN NK CELLS BY MHC CLASS-I AND KILLER INHIBITORY RECEPTORS (KIR), The FASEB journal, 12(4), 1998, pp. 3512-3512
Authors:
MIZUTANI Y
YOSHIDA O
BONAVIDA B
Citation: Y. Mizutani et al., SENSITIZATION OF HUMAN BLADDER-CANCER CELLS TO FAS-MEDIATED CYTOTOXICITY BY CIS-DIAMMINEDICHLOROPLATINUM(II), The Journal of urology, 160(2), 1998, pp. 561-570
Authors:
MIZUTANI Y
YOSHIDA O
BONAVIDA B
Citation: Y. Mizutani et al., PROGNOSTIC-SIGNIFICANCE OF SOLUBLE FAS IN THE SERUM OF PATIENTS WITH BLADDER-CANCER, The Journal of urology, 160(2), 1998, pp. 571-576
Authors:
DEMIDEM A
LAM T
ALAS S
HARIHARAN K
HANNA N
BONAVIDA B
Citation: A. Demidem et al., CHIMERIC ANTI-CD20 (IDEC-C2B8) MONOCLONAL-ANTIBODY SENSITIZES A B-CELL LYMPHOMA CELL-LINE TO CELL-KILLING BY CYTOTOXIC DRUGS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(3), 1997, pp. 177-186
Authors:
USLU R
BORSELLINO N
FROST P
GARBAN H
NG CP
MIZUTANI Y
BELLDEGRUN A
BONAVIDA B
Citation: R. Uslu et al., CHEMOSENSITIZATION OF HUMAN PROSTATE CARCINOMA CELL-LINES TO ANTI-FAS-MEDIATED CYTOTOXICITY AND APOPTOSIS, Clinical cancer research, 3(6), 1997, pp. 963-972
Authors:
WIDNEY D
VANDERMEIJDEN M
MILES S
BONAVIDA B
DETELS R
MARTINEZMAZA O
Citation: D. Widney et al., ELEVATION OF SERUM-SOLUBLE CD27 LEVELS IN AIDS AND AIDS-ASSOCIATED LYMPHOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 121-121
Authors:
MIZUTANI Y
YOSHIDA O
TOIDA I
KURODA S
BONAVIDA B
Citation: Y. Mizutani et al., ANTIBACTERIAL ACTIVITY OF ADRIAMYCIN AGAINST BACILLUS-CALMETTE-GUERIN, Oncology Reports, 4(5), 1997, pp. 909-911
Authors:
MIZUTANI Y
TERACHI T
KAKEHI Y
OKADA Y
YOSHIDA O
BONAVIDA B
Citation: Y. Mizutani et al., LOW TOXICITY OF INHALED INTERFERON-GAMMA IN 4 PATIENTS WITH LUNG METASTASIS FROM RENAL-CELL CARCINOMA, Oncology Reports, 4(1), 1997, pp. 39-41
Authors:
BONAVIDA B
DALESSANDRO N
Citation: B. Bonavida et N. Dalessandro, GENETIC AND IMMUNOCHEMOTHERAPEUTIC APPROACHES IN CANCER-TREATMENT - PROCEEDINGS OF THE 43RD COURSE OF THE INTERNATIONAL-SCHOOL-OF-PHARMACOLOGY ERICE, ITALY, MAY 21-26, 1996 - PREFACE, Oncology Reports, 4, 1997, pp. 199-199
Authors:
BONAVIDA B
SAFRIT J
MORIMOTO H
MIZUTANI Y
USLU R
BORSELLINO N
FROST P
BEREK J
BELLDEGRUN A
ZIGHELBOIM J
NG CP
MORI S
Citation: B. Bonavida et al., CROSS-RESISTANCE OF TUMOR-CELLS TO CHEMOTHERAPY AND IMMUNOTHERAPY - APPROACHES TO REVERSE RESISTANCE AND IMPLICATIONS IN GENE-THERAPY (REVIEW), Oncology Reports, 4, 1997, pp. 201-205
Authors:
MIZUTANI Y
YOSHIDA O
BONAVIDA B
Citation: Y. Mizutani et al., BACILLUS-CALMETTE-GUERIN (BCG) IN THE TREATMENT OF SUPERFICIAL BLADDER-CANCER - DEVELOPMENT OF RESISTANCE TO BCG AND STRATEGIES FOR OVERCOMING RESISTANCE TO BCG (REVIEW), International journal of oncology, 11(1), 1997, pp. 79-86
Authors:
BAEK JH
BERTOLAMI CN
BONAVIDA B
PARK NH
Citation: Jh. Baek et al., NORMAL HUMAN ORAL KERATINOCYTES ARE MORE SENSITIVE TO N-METHYL-N'-NITRO-N-NITROSOGUANIDINE-INDUCED CYTOTOXICITY AND APOPTOSIS THAN HPV-IMMORTALIZED ORAL KERATINOCYTES - ROLE OF P53, International journal of oncology, 10(1), 1997, pp. 47-51
Authors:
MORI S
JEWETT A
MURAKAMIMORI K
CAVALCANTI M
BONAVIDA B
Citation: S. Mori et al., THE PARTICIPATION OF THE FAS-MEDIATED CYTOTOXIC PATHWAY BY NATURAL-KILLER-CELLS IS TUMOR-CELL-DEPENDENT, Cancer immunology and immunotherapy, 44(5), 1997, pp. 282-290
Authors:
FROST P
USLU R
BELLDEGRUN A
BONAVIDA B
Citation: P. Frost et al., CHEMOSENSITIZATION OF HUMAN PROSTATE CARCINOMA CELL-LINES TO FAS-MEDIATED CYTOTOXICITY BY TIL, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1816-1816
Authors:
FROST P
USLU R
BELLDEGRUN A
BONAVIDA B
Citation: P. Frost et al., CD4 T-CELL MEDIATED APOPTOSIS OF MELANOMA-CELLS DOES NOT INVOLVE FAS CD95 PATHWAYS, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1817-1817
Authors:
JEWETT A
BONAVIDA B
Citation: A. Jewett et B. Bonavida, INVOLVEMENT OF THE ADHESION MOLECULES LFA-1 AND ICAM-1 IN NK-INDUCED APOPTOSIS, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1855-1855
Authors:
JEWETT A
CAVALCANTI M
GIORGI J
BONAVIDA B
Citation: A. Jewett et al., CONCOMITANT KILLING IN-VITRO OF BOTH GP120-COATED CD4(-LYMPHOCYTES AND NATURAL-KILLER-CELLS IN THE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY(ADCC) SYSTEM() PERIPHERAL T), The Journal of immunology, 158(11), 1997, pp. 5492-5500
Authors:
JEWETT A
CAVALCANTI M
BONAVIDA B
Citation: A. Jewett et al., PIVOTAL ROLE OF ENDOGENOUS TNF-ALPHA IN THE INDUCTION OF FUNCTIONAL INACTIVATION AND APOPTOSIS IN NK CELLS, The Journal of immunology, 159(10), 1997, pp. 4815-4822
Authors:
FROST P
NG CP
BELLDEGRUN A
BONAVIDA B
Citation: P. Frost et al., IMMUNOSENSITIZATION OF PROSTATE CARCINOMA CELL-LINES FOR LYMPHOCYTES (CTL, TIL, LAK)-MEDIATED APOPTOSIS VIA THE FAS-FAS-LIGAND PATHWAY OF CYTOTOXICITY, Cellular immunology, 180(1), 1997, pp. 70-83
Authors:
MIZUTANI Y
OKADA Y
YOSHIDA O
FUKUMOTO M
BONAVIDA B
Citation: Y. Mizutani et al., DOXORUBICIN SENSITIZES HUMAN BLADDER-CARCINOMA CELLS TO FAS-MEDIATED CYTOTOXICITY, Cancer, 79(6), 1997, pp. 1180-1189
Authors:
DOERING LV
VREDEVOE DL
WOO MA
FONAROW GC
SKOTSKO C
BONAVIDA B
Citation: Lv. Doering et al., PREDICTORS OF NATURAL-KILLER CELL-MEDIATED CYTOTOXICITY DEFICIENCY INADVANCED HEART-FAILURE SECONDARY TO EITHER ISCHEMIC OR IDIOPATHIC DILATED CARDIOMYOPATHY, The American journal of cardiology, 80(2), 1997, pp. 234-236
Authors:
MIZUTANI Y
OKADA Y
YOSHIDA O
BONAVIDA B
Citation: Y. Mizutani et al., SIGNIFICANCE OF CYTOTOXIC ACTIVITY OF PERIPHERAL-BLOOD LYMPHOCYTES AGAINST AUTOLOGOUS TUMOR-CELLS IN PATIENTS WITH BLADDER-CANCER, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(6), 1996, pp. 385-391